Microneedle-Assisted Skin Permeation by Non-toxic Bioengineerable Gas Vesicle Nanoparticles

dc.contributor.authorAndar, Abhay
dc.contributor.authorKaran, Ram
dc.contributor.authorPecher, Wolf T
dc.contributor.authorDassarma, Priya
dc.contributor.authorHedrich, William
dc.contributor.authorStinchcomb, Audra L
dc.contributor.authorDassarma, Shiladitya
dc.date.accessioned2017-06-23T19:31:18Z
dc.date.available2017-06-23T19:31:18Z
dc.date.issued2017
dc.description.abstractGas vesicle nanoparticles (GVNPs) are hollow, buoyant protein organelles produced by the extremophilic microbe Halobacterium sp. NRC-1 and are being developed as bioengineerable and biocompatible antigen and drug-delivery systems (DDS). Dynamic light scattering measurements of purified GVNP suspensions showed a mean diameter of 245 nm. In vitro diffusion studies using Yucatan miniature pig skin showed GVNP permeation to be enhanced after MN-treatment compared to untreated skin. GVNPs were found to be non-toxic to mammalian cells (human kidney and rat mycocardial myoblasts). These findings support the use of GVNPs as DDS for intradermal/transdermal permeation of protein- and peptide-based drugs.en_US
dc.format.extent6 pagesen_US
dc.genrejournal articlesen_US
dc.identifierdoi:10.13016/M2K35MD15
dc.identifier.citationAbhay U. Andar, Ram Karan, Wolf T. Pecher, Priya DasSarma, William D. Hedrich, Audra L. Stinchcomb, and Shiladitya DasSarma. Microneedle-Assisted Skin Permeation by Nontoxic Bioengineerable Gas Vesicle Nanoparticles. Molecular Pharmaceutics 2017 14 (3), 953-958.en_US
dc.identifier.uri10.1021/acs.molpharmaceut.6b00859
dc.identifier.urihttp://hdl.handle.net/11603/4185
dc.language.isoen_USen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.isAvailableAtUniversity of Baltimore
dc.titleMicroneedle-Assisted Skin Permeation by Non-toxic Bioengineerable Gas Vesicle Nanoparticlesen_US
dc.typeTexten_US

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: